Evidence Hub

Unveiling Transformation from Electrochemical Biosensors to Commercial Point-of-Care Devices: A Case Study for SARS-CoV-2

Ayyappa Bathinapatla, M. Manuel, Aseena Azeez, Rajasekhar Chokkareddy, S. Kanchi

Journal of the Electrochemical Society, 2025

3 citations

Abstract

Infectious diseases, triggered by pathogens such as bacteria, viruses, or parasites, propagate through contact, vectors, or environmental sources, often intensifying pandemics and causing significant societal disruptions. These diseases can severely impact global economies, employment, mental well-being, and public health. The rapid mutation of pathogens like SARS-CoV-2 complicates detection and treatment, making timely intervention crucial. Electrochemical biosensors, developed with advanced nanostructured biorecognition units and electroanalytical techniques, are central to addressing the challenges posed by SARS-CoV-2. The state-of-the-art research on electrochemical biosensors for SARS-CoV-2 diagnosis is thoroughly summarized in this review. These consist of the identification of spike protein (S protein)/RBD, nucleocapsid protein (N protein), antibodies, nucleic acids (RNA and DNA), entire viruses and some of the biomarkers. Point-of-care (POC) devices have become essential in the fight against the pandemic, enabling rapid diagnosis, early treatment, and effective containment. They increase testing accessibility, reduce viral transmission, and ultimately save lives. This review highlights the latest advancements in electrochemical biosensors. It offers an overview of currently available POC devices/diagnostic tools (a total 55 assay kits and devices) and the challenges of translating laboratory research into practical, deployable technologies. Additionally, the…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free